Zamudio, RoxanaHijazi, KarolinJoshi, ChaitanyaAitken, EmmaOggioni, Marco R.Gould, Ian M.2020-03-022020-03-022019-06Zamudio, R, Hijazi, K, Joshi, C, Aitken, E, Oggioni, M R & Gould, I M 2019, 'Phylogenetic analysis of resistance to ceftazidime/avibactam, ceftolozane/tazobactam and carbapenems in piperacillin/tazobactam-resistant Pseudomonas aeruginosa from cystic fibrosis patients', International Journal of Antimicrobial Agents, vol. 53, no. 6, pp. 774-780. https://doi.org/10.1016/j.ijantimicag.2019.02.0220924-8579Mendeley: 71996a89-4381-39fc-a029-3d9b49edbc3eORCID: /0000-0002-8589-2129/work/59177121https://hdl.handle.net/2164/13764ACKNOWLEDGEMENTS We thank the staff of the Medical Microbiology Laboratory at Aberdeen Royal Infirmary for their dedicated support to this study. We thank the Oxford Genomics Centre at the Wellcome Centre for Human Genetics (funded by Wellcome Trust grant reference 203141/Z/16/Z) for the generation and initial processing of the sequencing data. FUNDING This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.71095102engSDG 3 - Good Health and Well-beingPseudomonas aeruginosacystic fibrosisceftazidime/avibactamceftolozane/tazobactamampCAmpDoprDmutation-driven evolutionCeftolozane/tazobactamCystic fibrosisCeftazidime/avibactamR Medicine (General)Microbiology (medical)Infectious DiseasesPharmacology (medical)Wellcome Trust203141/Z/16/ZSupplementary DataR1Journal article10.1016/j.ijantimicag.2019.02.022http://www.scopus.com/inward/record.url?scp=85064169470&partnerID=8YFLogxKhttp://www.mendeley.com/research/phylogenetic-analysis-resistance-ceftazidimeavibactam-ceftolozanetazobactam-carbapenems-piperacillin536